|
|
|
(18.216.24.243)
|
|
Users online: 19485
|
|
|
|
|
|
|
Ijournet
|
|
|
|
|
|
|
Biopharmaceutics Classification System (BCS) and Biowaivers: Role in Drug Product Design Sharma Anshu1,*, Jain CP1, Ashawat MS2 1Department of Pharmaceutical Sciences, M.L.S. University, Udaipur (Rajasthan) 2B.N. Girls College of Pharmacy, Udaipur, (Rajasthan) *Corresponding Author E-mail: anshukiransharma@yahoo.com
Abstract The introduction of the Biopharmaceutics Classification System (BCS) into the Food and Drug Administration is a major step forward to classify the biopharmaceutical properties of drugs and drug products. Based on the mechanistic approaches to the drug absorption and dissolution process, the BCS enables the regulatory bodies to simplify and improve the drug approval process. The knowledge of BCS of drug in a formulation can also be utilized by the formulation scientist to develop a more optimized dosage form. Top Keywords Biopharmaceutics Classification System, Biowaivers, IVIVC, solubility. Top | |
|
|
|
|
║ Site map
║
Privacy Policy ║ Copyright ║ Terms & Conditions ║
|
|
|
751,437,041 visitor(s) since 30th May, 2005.
|
|
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
|
|
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.
|